Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
2000 2
2001 2
2002 1
2003 1
2006 1
2007 4
2008 3
2009 5
2010 8
2011 10
2012 4
2013 6
2014 7
2015 11
2016 17
2017 8
2018 8
2019 6
2020 17
2021 15
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: matthews gv. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
Tea F, Ospina Stella A, Aggarwal A, Ross Darley D, Pilli D, Vitale D, Merheb V, Lee FXZ, Cunningham P, Walker GJ, Fichter C, Brown DA, Rawlinson WD, Isaacs SR, Mathivanan V, Hoffmann M, Pöhlman S, Mazigi O, Christ D, Dwyer DE, Rockett RJ, Sintchenko V, Hoad VC, Irving DO, Dore GJ, Gosbell IB, Kelleher AD, Matthews GV, Brilot F, Turville SG. Tea F, et al. Among authors: matthews gv. PLoS Med. 2021 Jul 6;18(7):e1003656. doi: 10.1371/journal.pmed.1003656. eCollection 2021 Jul. PLoS Med. 2021. PMID: 34228725 Free PMC article.
HIV and hepatitis C coinfection.
Matthews GV, Rockstroh J. Matthews GV, et al. Curr Opin HIV AIDS. 2011 Nov;6(6):449-50. doi: 10.1097/COH.0b013e32834bbf85. Curr Opin HIV AIDS. 2011. PMID: 22001889 No abstract available.
Treatment of acute HCV infection.
Grebely J, Matthews GV, Dore GJ. Grebely J, et al. Among authors: matthews gv. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):265-74. doi: 10.1038/nrgastro.2011.32. Epub 2011 Mar 22. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21423258 Review.
HIV and hepatitis C coinfection.
Matthews GV, Dore GJ. Matthews GV, et al. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.
Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
Hajarizadeh B, Grebely J, Martinello M, Matthews GV, Lloyd AR, Dore GJ. Hajarizadeh B, et al. Among authors: matthews gv. Lancet Gastroenterol Hepatol. 2016 Dec;1(4):317-327. doi: 10.1016/S2468-1253(16)30075-9. Epub 2016 Nov 10. Lancet Gastroenterol Hepatol. 2016. PMID: 28404202 Review.
146 results